About Takashi Kiyoizumi
Takashi Kiyoizumi is CEO, Director of the Board at BTB Therapeutics.
Experience
This experience comes from Takashi Kiyoizumi's profile and from SEC filings. For roles taken from filings, the years are when the filings name Takashi Kiyoizumi in the role, so the role may have started earlier or lasted longer.
BTB Therapeutics, Inc. Current
CEO, Director of the Board
Chief Executive Officer (2023 – Present)
2023 – Present · Escondido, CA
Develops non-opioid pain medicines and treatments for rare genetic diseases and cancer.
AA
Autoimmunity BioSolutions (ABS) Current
Board Advisor
2021 – Present
SS
School of Health Innovation, Kanagawa University of Human Services Current
Guest Professor
2019 – Present
TI
Thrive Bioscience, Inc. Current
Advisor to Chief Executive Officer
2017 – Present
KL
Kiyoizumi Advisory LLC Current
Managing Director
2013 – Present
NG
NuFund Venture Group Current
Member
2006 – Present
JD
JFIT, UC San Diego
Executive Manager
2015 – 2026
BI
BioPacific Investors
Member
2013 – 2026
AL
AIFAM Group LLC
Senior Advisor (Life Science)
2020 – 2023
TT
Trius Therapeutics
Director of the Board
2005 – 2008
MI
MediciNova, Inc.
President & CEO
2000 – 2005
TU
Tanabe Research Laboratories, USA
President and CEO
2000 – 2002
Key Colleagues at Startups
The people Takashi Kiyoizumi works with at each company, as listed on that company's latest Form D.
BTB Therapeutics, Inc. · Form D/A, Aug 12, 2026
Masatoshi Hagiwara
Chief Scientific Officer, Director of the Board
David Snyder
Director of the Board
Nobuhiro Yagi
Director of the Board
SY
Sidney Yee
Director